Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
"Bacterial anaerobic metabolism" is a broad metabolic process, not a single molecule or discrete druggable target. It encompasses the network of biochemical reactions used by bacteria to generate energy (ATP) and maintain redox balance when oxygen is not available[1][3][5]. Key pathways include glycolysis followed by fermentation and/or anaerobic respiration (using nitrate, sulfate, etc. as terminal electron acceptors)[3][5][6]. Anaerobic metabolism enables pathogens to persist in hypoxic environments such as biofilms, chronic wounds, or cystic fibrosis lungs, often leading to increased resistance to antibiotics and clinical treatment failure[4][6]. Rather than one molecular target, drug discovery has focused on critical enzymes, essential metabolites, or regulatory circuits controlling these metabolic pathways (for example, nitrate reductases, biotin-containing decarboxylases, or systems like Rnf)[1][8]. Manipulating anaerobic metabolism—either by metabolic reprogramming or directly inhibiting essential anaerobic enzymes—represents an emerging strategy to enhance antibiotic efficacy and combat drug tolerance, but "bacterial anaerobic metabolism" as a whole is not a single, canonical therapeutic target[2][8]. **Note:** - "Bacterial anaerobic metabolism" is not a specific molecular target (like a receptor, enzyme, transporter, etc.), so `is_target = false` and `is_incorrect = true`. - Related druggable targets include individual enzymes or pathways within this metabolic system (for example, nitrate reductase, biotin-containing decarboxylases), but the system as a whole is too broad and non-specific for conventional target annotation[1][6][8].
Potentiation of antibiotic effect by altering metabolic state and membrane permeability[2] - Antibiotic killing suppressed or enhanced depending on metabolic/respiratory state[4][6] - Inhibition or rerouting of metabolic pathways (e.g., blocking fermentation, nitrate respiration)[2][4][6]
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial anaerobic metabolism.